Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Okay you number crunchers
As I said a few weeks ago, if there was latitude to work with, I think it preferable to be in Q1. We already know the annual will blow out the prior annual, so need to pile on there. Sony in Q1 should make the Q1 comp's a blowout, and also gives an early leg up on fiscal year ending 5/07 beating FY 5/06. It all keeps 'Big Mo' moving.
Share
New Message
Please login to post a reply